Mather Group’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.39K Buy
+150
New +$3.37K ﹤0.01% 1679
2025
Q4
Sell
-150
Closed -$3.95K 993
2025
Q3
$3.95K Buy
+150
New +$3.86K ﹤0.01% 1441
2025
Q2
Sell
-150
Closed -$3.73K 997
2025
Q1
$3.73K Hold
150
﹤0.01% 1457
2024
Q4
$3.4K Hold
150
﹤0.01% 1441
2024
Q3
$3.19K Hold
150
﹤0.01% 1384
2024
Q2
$2.89K Sell
150
-10
-6% -$204 ﹤0.01% 1782
2024
Q1
$3.33K Buy
+160
New +$3.17K ﹤0.01% 1434

Other funds holding FMS

Mather Group's FMS Position: Q2 2026 in Review

Mather Group opened a new position in Fresenius Medical Care (FMS) in Q2 2026: 150 shares worth $3.39K. The stake represents ﹤0.01% of the portfolio and ranks #1679 among its holdings. This is a return to the name: Mather Group previously reported a position in FMS as recently as Q3 2025.

Mather Group first reported a position in FMS in Q1 2024 and has held it in 7 quarters since. The position peaked at $3.95K in Q3 2025. 233 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Mather Group held 150 shares of Fresenius Medical Care worth $3.39K as of Q2 2026.
  • Fresenius Medical Care was a new Mather Group position in Q2 2026.
  • Fresenius Medical Care made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1679 holding.
  • Mather Group first reported a position in Fresenius Medical Care in Q1 2024 and has held it in 7 quarters since.
  • Mather Group's Fresenius Medical Care position peaked at $3.95K in Q3 2025.
  • 233 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.